Capsule Endoscopy: Poised For Growth
The market for capsule endoscopy is one of the fastest growing segments in the multibillion-dollar gastrointestinal endoscopy market. The market opportunity is vast and highly underpenetrated, and an increasing number of competitors, new product innovations, and expanding indications for the technology are positioning capsule endoscopy as a market poised for growth – particularly if the technology is proven and FDA cleared for colon cancer indications.
You may also be interested in...
The $860 million purchase agreement will give Covidien the dominant capsule endoscopy platform on the market as the company hopes for FDA approval this year of PillCam COLON 2 as a less invasive alternative for patients who are unable to undergo a colonoscopy.
Advances in imaging and interventional endoscopy are improving cancer detection and enabling less invasive approaches to diagnose and treat disorders in the gastrointestinal tract. These emerging procedures are poised to fuel growth in the $7 billion global market for GI endoscopy.
Trends In Colorectal Cancer Screening – The Impact Of Health Care Reform: An Interview With Brian Jacobson, MD
Medtech Insight recently spoke with Brian Jacobson, MD, associate professor of medicine at Boston University School of Medicine, and the chair of the American Society for Gastrointestinal Endoscopy’s Health and Public Policy Committee, about trends in colorectal cancer screening and the potential impact that health care reform will have on the colonoscopy market.